On this episode, I was joined by Marta New, the CEO of Radyus Research. Dr. New discusses:

• 0:00 Intro
• 1:37 Pre-Clinical Planning
• 7:15 What’s the purpose of an IND?
• 14:10 Administration Route Selection
• 19:00 Candidate Selection and Animal Models
• 30:10 Pre-IND Meeting
• 44:00 IND Submissions and Approval

Marta New PhD MBA is the CEO of Radyus Research. She is an experienced drug developer with a background in early-stage venture capital, considerable pharma R&D, and university technology transfer.